Comparison of 5-FU versus capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer

被引：3
|
作者：
Yu, Irene S.
Cheung, Winson Y.
机构：
[1] British Columbia Canc Agcy, Vancouver, BC, Canada
[2] BC Canc Agcy, Dept Med Oncol, Vancouver, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.680
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
680
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparison of 5-FU vs capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer.
    Yu, Irene
    Cheung, Winson Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Economic assessment of capecitabine/cisplatin versus 5-FU/cisplatin regimens in adjuvant treatment of advanced gastric cancer in Spain
    Safont, M.
    Darba, J.
    Restovic, G.
    Sastre, J.
    Bellmunt Molins, J.
    Gomez, M. A.
    Salgado, M.
    Vila, C.
    Ramirez De Arellano, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] A comparison between 5-fluorouracil/mitomycin and capecitabine/mitomycin in combination with radiation for anal cancer
    Peixoto, Renata D'Alpino
    Wan, Dante D.
    Schellenberg, Devin
    Lim, Howard J.
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (04) : 665 - 672
  • [4] ECONOMIC ASSESSMENT OF CAPECITABINE/CISPLATIN VERSUS 5-FU/CISPLATIN REGIMENS IN ADJUVANT TREATMENT OF ADVANCED GASTRIC CANCER IN SPAIN
    Darba, J.
    Restovic, G.
    Ramirez de Arellano, A.
    Safont, M.
    Sastre, J.
    Bellmunt, J.
    Gomez, M.
    Salgado, M.
    Vila, C.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 184 - 184
  • [5] COMPARISON OF CISPLATIN AND MITOMYCIN/5-FU AS RADIOSENSITIZERS IN THE TREATMENT OF VULVAR CANCER - RESULTS OF A SINGLE INSTITUTIONAL COHORT STUDY
    Linz, V.
    Schwanbeck, C.
    Anic, K.
    Jaekel, J.
    Schmidt, M. W.
    Krajnak, S.
    Schwab, R.
    Weikel, W.
    Seeger, A.
    Schmidt, M.
    Schmidberger, H.
    Hasenburg, A.
    Battista, M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A350 - A350
  • [6] CHEMORADIOTHERAPY WITH 5-FU VERSUS CAPECITABINE ON RECTAL CANCER DOWNSTAGING
    Aguas, L.
    Salgado, M.
    Davila, C.
    Costa, A. S.
    Almeida, D.
    Barbosa, M.
    Caeiro, C.
    Sarmento, C.
    Marques, M.
    Damasceno, M.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 211 - 211
  • [7] A 20-year comparison of definitive chemoradiation with 5-FU versus capecitabine in anal cancer patients treated at Stanford.
    Pumpalova, Yoanna S.
    Kozak, Margaret M.
    von Eyben, Rie
    Fisher, George A.
    Kunz, Pamela L.
    Chang, Daniel Tandel
    Haraldsdottir, Sigurdis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [8] AN ECONOMIC EVALUATION OF CAPECITABINE/CISPLATIN PLUS 5-FU/CISPLATIN REGIMENS IN TREATMENT OF ADVANCED GASTRIC CANCER IN SPAIN
    Darba, J.
    Restovic, G.
    Ramirez de Arellano, A.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A466 - A466
  • [9] Concurrent radiochemotherapy with 5-FU/mitomycin remains standard treatment for anal carcinoma
    Nieder, C.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (06) : 512 - 513
  • [10] Postoperative adjuvant 5-FU/cisplatin and chemoradiation with capecitabine for advanced gastric cancer
    Lee, H.
    Choi, Y.
    Hur, W.
    Kown, H.
    Kim, M.
    Jung, G.
    Choi, H-J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S526 - S526
12345